| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-13 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-13 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-12 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |